Seminar Series on allogeneic hematopoietic cell transplantation
As the pandemic situation has limited travel and exchange throughout the last twelve months, Francesco Dazzi, Victoria Potter and Martin Bornh user, together with colleagues from King’s and TUD have initiated an interactive lecture series on specific aspects of allogeneic hematopoietic cell transplantation. Brief state-of-the art lectures will be followed by case-vignettes on clinical problems with one colleague from King’s and TUD each, discussing local policies and general therapeutic approaches.
- Prof. Francesco Dazzi (King‘s)
- Dr. Victoria Potter (King‘s)
- Prof. Martin Bornh user (TUD)
Acute Myeloid Leukaemia and Hematopoietic Cell Transplantation
The transCampus cooperation between TUD and King‘s PIs focusses on Mesenchymal Stromal Cells and their clinical use, the in depth characterization of AML progenitors and the optimization of cell-based immunotherapies.
- development and GMP manufacture of viral vectors (gamma-retro and lenti) for clinical applications
- development of programmable vectors that are able to respond to physiological cues
- manufacture of over 150 batches of vectors for early phase clinical trials (gene therapy)
- Prof. Farzin Farzaneh (King‘s)